About the offering
Smartweave is a therapeutic platform company developing personalized, bio-compatible solutions for soft tissue repair and regeneration. The company combines AI, virtual human twin technology, 3D printing, and regenerative biology to create patient-specific medical devices and treatments. Technology Platform Smartweave's approach uses AI and machine learning to integrate patient physiological data, demographics, and medical history to create risk classifications and personalized treatment recommendations. The company creates "digital twins"—virtual representations of each patient—that guide the design of bespoke drug-device combinations. Medical imaging data informs the shape and mechanical properties of supportive hydrogels or structural meshes tailored to individual anatomy, while physiological data helps classify recurrence and complication risk. As a member of Dassault Systèmes' 3DEXPERIENCE Lab accelerator (one of only three startups chosen globally), Smartweave leverages their platform for designing customizable scaffold and therapeutic combinations through rapid simulation and optimization. Product Pipeline The company has developed multiple regenerative solutions: HeraWeave (injectable hydrogels for stress urinary incontinence), OrthoWeave (bioprinted patches for tendon repair and mobility restoration), and CardioWeave (anatomically bespoke cardiac patches and valve replacements). All products are designed by AI to match patient anatomy and physiology while minimizing inflammatory response. Validation & Funding The company's affiliate and key clinical collaborators have secured $20M+ in non-dilutive commitments to de-risk the technology stack, including grants from NIH, NSF, and the California Institute of Regenerative Medicine, plus infrastructure support from Puerto Rico's Department of Economic Development. Market Opportunity Smartweave targets a $100B+ total addressable market for connective tissue restoration by 2030, with a serviceable obtainable market of $150M to $250M within five years across urogynecology, orthopedics, and cardiac applications.
FAQ
How much has Smartweave raised?
Smartweave has raised $285,826 of a $1.24M goal.
Where is Smartweave's campaign live?
The offering is live on Wefunder, an SEC-registered Reg CF intermediary.
What are the terms of Smartweave's raise?
SAFE, $35M cap.
When does Smartweave's offering close?
The stated close date is Apr 30, 2027.